ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2,3,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
2,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
3,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
5,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
6,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
7,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
8,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
10,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
10,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
11,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
11,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
12,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
12,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
12,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
12,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
14,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
14,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
14,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
14,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
14,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
14,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
15,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
16,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
16,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
16,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
17,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
17,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
17,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
18,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
18,2,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
19,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
20,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
21,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
22,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
22,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
23,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
24,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
25,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
27,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,2,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
28,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
29,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
30,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
31,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
32,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
33,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
34,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
35,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
38,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
38,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
39,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
39,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
39,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
39,5,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
39,6,Graft versus host disease oral,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
39,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
39,8,Mechanical urticaria,Urticarias,Angioedema and urticaria,Skin,N
39,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,10,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
39,11,Nutritional condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
39,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
40,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
40,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
40,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
40,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
43,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
44,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
45,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
45,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
45,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
45,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
47,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
47,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
47,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
48,2,Synovial rupture,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,Y
49,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
50,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
51,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
53,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
54,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
54,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,2,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,Y
55,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
56,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
57,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
57,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
